Poolbeg Pharma PLC Ordinary Shares (POLB)
Industry Biotechnology
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell
3.60p
Buy
4.10p
-0.05p (-1.35%)
Prices updated at 16 Dec 2025, 12:42 GMT
| Prices minimum 15 mins delay
Prices in GBX
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Sector
Healthcare
Industry
Biotechnology
Chairman
Mr. Cathal Martin Friel
CEO
Dr. Jeremy Skillington
Most recent earnings
31 Dec 2024
Fiscal year end
31 Dec 2024
Employees
10
Head office
42 New Road
London
United Kingdom
E1 2AX
Key personnel
Owner name | Salary |
|---|---|
Professor Brendan Buckley Non-Executive Director | - |
Mr. Ian O'Connell Executive Director, Chief Financial Officer | - |
Dr. Jeremy Skillington Executive Director, Chief Executive Officer | - |
Mr. Cathal Martin Friel Executive Director, Chairman | - |
Top 5 shareholders
Owner name | No. of shares |
|---|---|
| YFS Sterling Select Companies Fd | 5,042,590 |
Director dealings
Date | Action |
|---|---|
| 25 Jun 2025 | Purchase |
Please note that past performance is not a reliable indicator of future returns.